Literature DB >> 2813273

Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro-in vivo correlation and predictability with mixed solvent systems.

G A Brazeau1, H L Fung.   

Abstract

The potential of binary mixtures of propylene glycol-water, ethanol-water, and polyethylene glycol 400-water to cause skeletal muscle damage (myotoxicity) following intramuscular injection was examined with an in vitro model using the isolated rat muscle. At moderate concentrations (20-40%, v/v) of the organic cosolvent, the order of myotoxicity was propylene glycol greater than ethanol much greater than polyethylene glycol 400. The in vitro results were then compared with in vivo toxicity in rabbits after injection of normal saline, 40% (v/v) polyethylene glycol 400, 40% (v/v) propylene glycol, indocyanine green in normal saline, and indocyanine green in 40% (v/v) propylene glycol. Employing the area under the creatine kinase activity curve from 0 to 72 hr as the index of skeletal muscle damage, an excellent in vitro-in vivo correlation was observed. The basic myotoxicity relationships obtained from the binary cosolvent systems were then used to examine the myotoxicity of ternary organic cosolvent mixtures. Several mixed solvent systems with the same theoretical molar solubilization power for a model compound, diazepam, were selected to determine (1) if myotoxicity can be reduced by changing the composition of the ternary mixtures and (2) if myotoxicity of the individual components is additive. For the solvent systems containing propylene glycol, ethanol, and water, the total myotoxicity equaled the sum of the individual myotoxicity of each component. In contrast, for the solvent systems containing polyethylene glycol 400, the total myotoxicity was only half of the sum of individual toxicities. These results suggest that polyethylene glycol 400 in mixed cosolvent systems might have a protective effect on the myotoxicity generated by intramuscular injections.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2813273     DOI: 10.1023/a:1015971429942

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  A study of the polyethylene glycols as vehicles for intramuscular and subcutaneous Injection.

Authors:  C P CARPENTER; C B SHAFFER
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1952-01

2.  The toxicology of the polyethylene glycols.

Authors:  H F SMYTH; C P CARPENTER; C S WEIL
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1950-06

3.  Legitimate indications for intramuscular injections.

Authors:  P R Alper
Journal:  Arch Intern Med       Date:  1978-11

4.  [Muscular toxicity of polyols. IV].

Authors:  A Dominguez-Gil; R Cadorniga
Journal:  Farmaco Prat       Date:  1971-09

5.  Polyethylene glycol as a solvent for diazepam: bioavailability and clinical effects after intramuscular administration, comparison of oral, intramuscular and rectal administration, and precipitation from intravenous solutions.

Authors:  K Korttila; A Sothman; P Andersson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1976-07

6.  The loss of creatine phosphokinase (CK) from intramuscular injection sites in rabbits. A predictive tool for local toxicity.

Authors:  O Svendsen; F Rasmussen; P Nielsen; E Steiness
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1979-05

7.  Response of dogs to subcutaneous injections of various concentrations of propylene glycol with water.

Authors:  J M Brown; C W Kasson
Journal:  Am J Vet Res       Date:  1984-01       Impact factor: 1.156

8.  Intramuscular injection-site complications.

Authors:  D J Greenblatt; M D Allen
Journal:  JAMA       Date:  1978-08-11       Impact factor: 56.272

9.  An in vitro model to evaluate muscle damage following intramuscular injections.

Authors:  G A Brazeau; H L Fung
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

10.  Indocyanine green: pharmacokinetics in the rabbit and relevant studies of its stability and purity.

Authors:  R Heintz; C K Svensson; K Stoeckel; G J Powers; D Lalka
Journal:  J Pharm Sci       Date:  1986-04       Impact factor: 3.534

View more
  6 in total

Review 1.  Solubilizing excipients in oral and injectable formulations.

Authors:  Robert G Strickley
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

2.  Impact of intramuscular administration of lipid-soluble and water-soluble vehicles into regenerating muscle at the distinct phases of skeletal muscle regeneration.

Authors:  Ratchakrit Srikuea; Kanokwan Suhatcho
Journal:  J Physiol Sci       Date:  2017-11-13       Impact factor: 2.781

3.  Acute changes in muscle blood flow and concomitant muscle damage after an intramuscular administration.

Authors:  Pierre Jean Ferré; Eckart Thein; Isabelle Raymond-Letron; Pierre-Louis Toutain; Hervé Pierre Lefebvre
Journal:  Pharm Res       Date:  2005-03       Impact factor: 4.200

4.  Longitudinal analysis of gene expression in porcine skeletal muscle after post-injection local injury.

Authors:  Pierre J Ferré; Laurence Liaubet; Didier Concordet; Magali SanCristobal; Emmanuelle Uro-Coste; Gwenola Tosser-Klopp; Agnès Bonnet; Pierre-Louis Toutain; François Hatey; Hervé P Lefebvre
Journal:  Pharm Res       Date:  2007-03-23       Impact factor: 4.200

5.  In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery.

Authors:  G A Brazeau; S Attia; S Poxon; J A Hughes
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

6.  Approach-aversion in calves following injections.

Authors:  Thomas Ede; Marina A G von Keyserlingk; Daniel M Weary
Journal:  Sci Rep       Date:  2018-06-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.